Ingestible Bioimpedance Capsule for Non-Invasive GI Tract Monitoring
A wireless capsule that non-invasively measures the bioimpedance of GI tract tissues for health monitoring.
Background
The field of medical diagnostics has long sought minimally invasive methods to assess the health of internal organs, including the GI tract. Traditional approaches often involve endoscopic procedures, which can be uncomfortable, require sedation, and carry risks of complications. The need for a non-invasive yet direct method for monitoring the health and identifying issues within the GI tract, particularly in the small intestine, has been a particular challenge in medical technology.
Current diagnostic methods for gastrointestinal health are limited in their ability to safely and directly measure conditions within the small intestine. This is largely due to the complexity and inaccessibility of the small intestine, making it difficult to assess without subjecting patients to invasive procedures like biopsy or endoscopy. These approaches are not only uncomfortable but also have an inherent risk of complications and cannot provide continuous or real-time data, which reduces their effectiveness in constant monitoring of conditions like chronic inflammation or ischemic disorders.
Technology
This invention pertains to a range of devices that measure the bioimpedance of tissues within the gastrointestinal (GI) tract. The devices are realized in forms such as ingestible capsules, which are equipped with miniature sensors and electronic circuitry for wireless transmission of data. These capsules can be ingested or inserted into the body for direct contact with GI tract tissues, employing tetrapolar electrodes for bioimpedance measurement to monitor conditions like inflammation, ischemia, edema, or mucosal irregularities. The device’s innovative design features include bioimpedance sensors that make transmural contact with the intestinal tissue, an electronic packaging scheme using a biocompatible polymer or resin, and a sensor surface conformal to the capsule’s shape, as well as a signal acquisition and processing circuit capable of real-time wireless communication to an external receiver.
The technology stands out due to its non-invasive capability to assess the small intestine directly, an area not traditionally accessible through non-invasive means. This makes it a significant advancement over existing GI monitoring methods which tend to be more invasive and less targeted. Its novel approach to integrating microfabrication of sensors, biocompatible packaging, and wireless technology provides a unique solution to efficiently and effectively diagnose and monitor conditions of the GI tract without necessitating invasive procedures.
Benefits
- Non-invasive assessment of GI tract health.
- Real-time wireless communication of health data.
- Direct monitoring of small intestine conditions.
- Reduced need for invasive procedures and associated risks.
- Enhanced patient comfort and convenience.
Applications
- Non-invasive gastrointestinal diagnosis and health monitoring.
- Real-time monitoring of inflammatory bowel disease and other chronic GI conditions.
- Early detection of ischemia and edema within the GI tract.
- In-clinic or at-home monitoring for post-operative recovery of GI surgery patients.
- Pharmaceutical research to assess drug effects on GI tract health.